Skip to main content

Table 2 Utility values for modeled health states [19, 20]

From: Cost effectiveness of ulcerative colitis treatment in Germany: a comparison of two oral formulations of mesalazine

Health State

Utility (SD)

Disease severity/Assumptions

Active UC: 1st line

0.589 (0.269)

Mild-to-moderate active disease (SCAI = 4-10)

Active UC: 1st line increased dosage

0.589 (0.269)

Mild-to-moderate active disease (SCAI = 4-10)

Active UC: 2nd line

0.589 (0.269)

Mild-to-moderate active disease (SCAI = 4-10)

Active UC: Failure/relapse

0.317 (0.315)

Severely active disease (SCAI > 10)

Surgery

0.317 (0.315)

Assumption: utility is equal to the utility of patients with relapse

Post surgery

0.845 (0.195)

Assumption: utility is equal to the utility of patients in remission

Remission

0.845 (0.195)

Patients in remission (SCAI < 4)